Sana Biotechnology Inc [NASDAQ: SANA] plunged by -$0.64 during the normal trading session on while it closed the day at $3.66.
Sana Biotechnology Inc stock has also gained 121.82% of its value over the past 7 days. However, SANA stock has declined by -8.27% in the 3 months of the year. Over the past six months meanwhile, it has lost -35.34% and gained 124.54% year-on date.
The market cap for SANA stock reached $817.16 million, with 223.11 million shares outstanding and 122.41 million shares in the current float. Compared to the average trading volume of 4.61M shares, SANA reached a trading volume of 29413808 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sana Biotechnology Inc [SANA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SANA shares is $10.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SANA stock is a recommendation set at 1.57. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
TD Cowen have made an estimate for Sana Biotechnology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2025. The new note on the price target was released on November 05, 2024, representing the official price target for Sana Biotechnology Inc stock. Previously, the target price had yet another raise to $16, while Rodman & Renshaw analysts kept a Buy rating on SANA stock.
The Average True Range (ATR) for Sana Biotechnology Inc is set at 0.67 The Price to Book ratio for the last quarter was 2.79, with the Price to Cash per share for the same quarter was set at 0.91.
SANA stock trade performance evaluation
Sana Biotechnology Inc [SANA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 121.82. With this latest performance, SANA shares gained by 38.11% in over the last four-week period, additionally sinking by -35.34% over the last 6 months – not to mention a drop of -29.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SANA stock in for the last two-week period is set at 67.52, with the RSI for the last a single of trading hit 72.04, and the three-weeks RSI is set at 62.84 for Sana Biotechnology Inc [SANA]. The present Moving Average for the last 50 days of trading for this stock 2.49, while it was recorded at 2.61 for the last single week of trading, and 5.37 for the last 200 days.
Sana Biotechnology Inc [SANA]: An insightful look at the core fundamentals
Sana Biotechnology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.47 and a Current Ratio set at 4.47.
Sana Biotechnology Inc [SANA]: Institutional Ownership
There are presently around $92.44%, or 101.18%% of SANA stock, in the hands of institutional investors. The top three institutional holders of SANA stocks are: FMR LLC with ownership of 27.17 million shares, which is approximately 12.5041%. FLAGSHIP PIONEERING INC., holding 25.0 million shares of the stock with an approximate value of $$136.51 million in SANA stocks shares; and FLAGSHIP PIONEERING INC., currently with $$70.32 million in SANA stock with ownership which is approximately 5.927%.
